From: Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
Factor | Average Onset n = 35 | Young Onset n = 39 | p-value |
---|---|---|---|
Male sex, n(%) | 20 (57%) | 17 (43%) | NS |
Family history of malignancy, n(%) | 13 (48%) | 13 (37%) | NS |
Smoking history, n(%) | 18 (49%) | 18 (49%) | NS |
HPpositive, n(%) | 7 (47%) | 8 (36%) | NS |
Proximal tumor location, n(%) | 11 (32%) | 7 (22%) | NS |
Signet ring cell, n(%) | 13 (37%) | 18 (55%) | NS |
Stage IV at diagnosis, n(%) | 3 (9%) | 9 (27%) | P < 0.05 |
HER2 positive, n(%) | 3 (9%) | 2 (5%) | NS |
EBV positive, n(%) | 13 (33%) | 4 (11%) | P < 0.05 |
Median OS, months | 47.8 months | 69.7 months | NS |